US 2023/0141913 A2 · PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY

Abstract

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.

Claims35

Dependent claims

The compound of claim 1 according to general formula (Ia) or a salt or solvate thereof.

Dependencies are inferred from the claim text.

Facts

Application

17/270,652Filed 23 Aug 2019

Priority

EP 18190774.224 Aug 2018

Published

11 May 2023

Term ends

Not estimatedThe source records don’t support an estimate.

Classification71 codes

A61K 31/5375
Having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines: 1,4-Oxazines, e.g. morpholine
A61K 31/04
Medicinal preparations containing organic active ingredients: nitro compounds
A61K 31/085
Ethers or acetals: having an ether linkage to aromatic ring nuclear carbon
A61K 31/09
Having an ether linkage to aromatic ring nuclear carbon: having two or more such linkages

Abstract

Claims35

Dependent claims

The compound of claim 1 according to general formula (Ia) or a salt or solvate thereof.

Dependencies are inferred from the claim text.

Phenoxy(hetero)aryl ethers of antiproliferactive activity

Life of this patent

Abstract

Claims35

Phenoxy(hetero)aryl ethers of antiproliferactive activity

Life of this patent

Abstract

Claims35